Form 4: Hims & Hers Health CFO Sells Shares

Sentiment:

Insider Transaction (Form 4)


Oluyemi Okupe, Chief Financial Officer of Hims & Hers Health, Inc., sold 7,163 shares of common stock on July 17, 2026 for $31.99 per share.

Summary

  • Option exercise/conversion: acquired 7,163 Class A Common Stock at $5.01 ($35,887) on July 17, 2026; holds 291,484 after (Direct).
  • Open-market sale: disposed of 7,163 Class A Common Stock at $31.99 ($229,168) on July 17, 2026; holds 284,321 after (Direct).
  • Option exercise/conversion: disposed of 7,163 Stock Option (right to buy) on July 17, 2026; holds 95,198 after (Direct).

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $229,168 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.

Insider Transactions

Oluyemi Okupe — Officer (Chief Financial Officer)

Transaction made under a Rule 10b5-1 trading plan.

DateTransactionSecuritySharesPriceValueHeld After
2026-07-17Option exercise/conversionClass A Common Stock7,163$5$35.9K291,484
2026-07-17Open-market saleClass A Common Stock7,163$32$229.2K284,321
2026-07-17Option exercise/conversionStock Option (right to buy)7,163——95,198

Key Dates

DateDescription
2026-07-17Option exercise/conversion (7,163 shares)
2026-07-17Open-market sale (7,163 shares)
2026-07-17Option exercise/conversion (7,163 shares)

Keywords

insider transaction, Form 4, HIMS, Hims & Hers Health, Inc., bearish, Oluyemi Okupe

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.